Explore advanced treatment options for gastrointestinal neuroendocrine tumors, focusing on real-world case studies and emerging clinical data.
A 66 Year Old Man with Progressive SSTR Positive Small Bowel Neuroendocrine Tumor with Hepatic Metastases
NCCN updates recommend cabozantinib for neuroendocrine tumors, offering flexibility in treatment options based on patient needs and prior therapies.